By bioluminescence in vivo imaging, we discovered that in all groups CD19 CAR-T cells exhibited immunotherapeutic properties (Figure 4H; Figure S4), but when analyzing the total flux of BLI emitted from cancer cells, the statistical significance was confirmed only in ABA groups (Table S1). The gene discussed is CD19; the disease is cancer.